STK38 and cancer: Considering further that STK38 knockout mice are viable and fertile with normal life spans [28, 56] and STK38 displays unique features in its regulatory and catalytic domains [26, 27], we propose that the development of pharmacological compounds that selectively target STK38 should be a feasible option for clinical approaches aiming to target “autophagy addicted” cancers.